A Food and Drug Administration advisory panel met to discuss regulatory approval for the Alzheimer's drug, Leqembi.
Share:
More In Science
SpaceX, NASA Mission Delayed Until Saturday
A SpaceX-NASA mission that was due to launch into orbit Friday was called off and delayed until Saturday.
Study: Wegovy Benefits People With Heart Condition
Diabetes and weight-loss drug Wegovy is shown to help people with a heart condition, according to a new study.
Your Friday Weather Forecast for Aug. 25, 2023
Cheddar News checks in with a coast-to-coast forecast of the weather for Friday, Aug. 25, 2023.
On A Positive Note: Painted Seashells to Raise Awareness Around Epilepsy
A Jersey Shore man has painted sea shells -- nearly 500 of them -- to raise awareness around epilepsy that have traveled as far as Asia and Australia.
Cape Cod Strands More Dolphins Than Anywhere Else. Now They're Getting Their Own Hospital
The International Fund for Animal Welfare, which protects animals worldwide, is opening a first-of-its-kind short-term dolphin hospital on Cape Cod this month that it hopes will not only improve survivability rates, but also enhance the research it has developed over 25 years.
Human-Like Robot Designed for Dull, Dangerous Tasks
A new humanoid robot designed to do dull and dirty jobs has been unveiled by NASA.
What's in Store for Mercury Retrograde 2023
The Mercury retrograde lasts until Sept. 15 as astrologers blame planets and stars for communications issues.
Study: Creativity Strengthens Children's Resilience
A new study suggests that teaching kids creativity can increase resilience.
Study: Marketers Overstate Fish Oil Benefits
A new study shows that marketers may be overstating fish oil benefits.
